What China’s low jab efficacy means for the global vaccination effort
Senior official raises fear over effectiveness of vaccines in wide use across Asia and Africa
A warning from China’s most senior disease control official that the country’s vaccines offer only limited protection against coronavirus has raised fears that the global vaccination effort could be less effective than first hoped.
Gao Fu, head of the Chinese Centre for Disease Control and Prevention, said at a press conference on Saturday that the current vaccines “don't have very high rates of protection”.
After what the BBC describes as a “rare admission of weakness” from within the highly secretive state, concern is growing that the vaccines, which are being widely used across Asia and Africa, may not effectively suppress the virus.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Vaccine efficacy
Gao said that China is considering mixing vaccines in an effort to “optimise” the effectiveness of the vaccines currently in use in China. He also suggested that altering the number of doses and the length of time between jabs could also boost efficacy rates.
His original comments were not reported in state-owned media, while in a later interview with the Global Times, the Chinese Communist Party’s (CCP) flagship paper, Gao appeared to row back, saying “protection rates of all vaccines in the world are sometimes high, and sometimes low.
“How to improve their efficacy is a question that needs to be considered by scientists around the world,” he told the paper, adding that the suggestion that China’s vaccines were not effective was a “complete misunderstanding” of his earlier comments.
China currently has five vaccines in use in its campaign: three inactivated-virus vaccines manufactured by Sinovac and Sinopharm, a one-shot vaccine from CanSino and a vaccine developed by Gao’s team and pharmaceutical company Anhui Zhifei Longcom.
Concerns have been raised about the efficacy of the China-developed vaccines before, with Sinovac’s CoronaVac, the most widely used of China’s vaccines, appearing to offer just 50.4% protection during late stage trials at the Butantan Institute in Brazil, the BBC reports.
While Sinovac’s “performance was better in Indonesia and Turkey”, preliminary trial results from Brazil showed that when two shots of the Sinovac vaccine were given less than three weeks apart, its effectiveness was 49.1%, “below the 50% threshold set by the World Health Organization”, Al Jazeera reports.
According to Oxford University tracking, China has administered 167.34 million Covid vaccines so far. All of the vaccines administered in China were developed locally, as Beijing has not authorised the use of any foreign-developed inoculations.
However, Gao’s warning about the vaccine’s efficacy has also caused concern outside China, as Beijing has also “struck deals to supply many of its allies and economic partners in the developing world”, The Washington Post says.
The Chinese government has distributed “hundred of millions of doses”, the paper adds, and has “boasted” that its jabs have been administered to world leaders in Indonesia, Pakistan and the UAE.
Global effort
China is “formally considering” options to change its vaccines to “solve the problem that the efficacy of the existing vaccines is not high”, Gao said during the press conference in Chengdu. And while Chinese media has moved to suppress the comments, “there have been signs that some countries remain skeptical” of the vaccines being delivered by China, The Washington Post says.
The UAE has openly experimented with administering three shots of the Sinopharm vaccine, as opposed to the two recommended by officials in Beijing, while Singapore is yet to begin the rollout of the Sinovac jab, which is instead being stockpiled.
China has been using the vaccine to increase its leverage over countries desperately scrambling for doses, with some countries “relying heavily on Chinese vaccines” in their inoculation campaigns, the BMJ says.
Indonesia, Malaysia, the Philippines, Thailand and Pakistan are the biggest buyers of China’s vaccine in Asia, the BBC reports, while Brazil, Mexico, Chile, Columbia and Ecuador have also “ordered millions of shots”. Turkey and Ukraine have signed contracts for CoronaVac, but it is Africa where China’s vaccines are “particularly important”, the broadcaster adds.
Zimbabwe, Somalia, Djibouti, Benin and Tunisia are all known to have received vaccines from China, with Beijing so far donating more than 96 million doses of its vaccine to 39 countries across the continent, according to independent consultancy Bridge Consulting.
As the world’s wealthier countries stockpile western-developed vaccines offering higher levels of protection, the CCP has “spent months touting Chinese vaccines as part of a soft power push”, The Washington Post says. “They have been in high demand” in lower-income nations, the paper adds, meaning poor efficacy rates could lend a blow to global efforts to suppress Covid infections.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Nigeria's worsening rate of maternal mortality
Under the radar Economic crisis is making hospitals unaffordable, with women increasingly not receiving the care they need
By Harriet Marsden, The Week UK Published
-
'Elevating Earth Day into a national holiday is not radical — it's practical'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
UAW scores historic win in South at VW plant
Speed Read Volkswagen workers in Tennessee have voted to join the United Auto Workers union
By Peter Weber, The Week US Published
-
Nigeria's worsening rate of maternal mortality
Under the radar Economic crisis is making hospitals unaffordable, with women increasingly not receiving the care they need
By Harriet Marsden, The Week UK Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
How happy is Finland really?
Today's Big Question Nordic nation tops global happiness survey for seventh year in a row with 'focus on contentment over joy'
By Harriet Marsden, The Week UK Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
How Tehran became the world's nose job capital
Under the radar Iranian doctors raise alarm over low costs, weak regulation and online influence of 'Western beauty standards'
By Harriet Marsden, The Week UK Published
-
Africa's renewed battle against female genital mutilation
Under the radar Campaigners call for ban in Sierra Leone after deaths of three girls as coast-to-coast convoy prepares to depart
By Harriet Marsden, The Week UK Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published